✦ LIBER ✦

Su1223 Efficacy and Safety of Adalimumab 80mg Weekly in Crohn's Disease

✍ Scribed by Bouguen, Guillaume; Laharie, David; Nancey, Stéphane; Hebuterne, Xavier; Flourie, Bernard; Filippi, Jérôme; Roblin, Xavier; Trang, Caroline; Boureille, A.; Babouri, Abdenour; Bretagne, Jean-François; Siproudhis, Laurent; Peyrin-Biroulet, Laurent

Book ID: 122320344
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 300 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)61590-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P522 Efficacy and safety of adalimumab 8

P522 Efficacy and safety of adalimumab 80 mg weekly in Crohn's disease

✍ Bouguen, G.; Laharie, D.; Nancey, S.; Hébuterne, X.; Flourié, B.; Filippi, J.; R 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 50 KB

Su1406 Efficacy, Safety, and Demographic

Su1406 Efficacy, Safety, and Demographics Factor of Adalimumab Therapy in 1693 Japanese Crohn's Disease Patients

✍ Ogata, Haruhiko; Watanabe, Mamoru; Matsui, Toshiyuki; Abe, Sadanori; Haruna, Shi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Efficacy and safety of infliximab and ad

Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study

✍ F. Zorzi; S. Zuzzi; S. Onali; E. Calabrese; G. Condino; C. Petruzziello; M. Asco 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

Efficacy and safety of adalimumab in Cro

Efficacy and safety of adalimumab in Crohn's disease: Meta-analysis of placebo-controlled trials

✍ Mei Lan HUANG; Zhi Hua RAN; Jun SHEN; Xiao Bo LI; Xi Tao XU; Shu Dong XIAO 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 445 KB

P072 A 3-WEEK COURSE OF 80MG WEEKLY ADMI

P072 A 3-WEEK COURSE OF 80MG WEEKLY ADMINISTERED ADALIMUMAB AS A RESCUE THERAPY FOR PATIENTS WITH CROHN'S DISEASE WHO LOST RESPONSE TO 40MG WEEKLY: RELATIONSHIP WITH ADALIMUMAB TROUGH SERUM LEVELS

✍ K. Karmiris; M. Noman; G. Paintaud; M. Ferrante; A. Duveau; D. Degenne; G. Van A 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 74 KB

W1132 A 3-Week Course of 80 Mg Weekly Ad

W1132 A 3-Week Course of 80 Mg Weekly Administered Adalimumab As a Rescue Therapy for Patients with Crohn's Disease Who Lost Response to 40 Mg Weekly: Relationship with Adalimumab Trough Serum Levels

✍ Karmiris, Konstantinos; Noman, Maja; Paintaud, Gilles; Ferrante, Marc; Duveau, A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 113 KB